Mark A. Winters

7.0k total citations
113 papers, 5.2k citations indexed

About

Mark A. Winters is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mark A. Winters has authored 113 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 69 papers in Virology and 32 papers in Epidemiology. Recurrent topics in Mark A. Winters's work include HIV Research and Treatment (69 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (36 papers). Mark A. Winters is often cited by papers focused on HIV Research and Treatment (69 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (36 papers). Mark A. Winters collaborates with scholars based in United States, United Kingdom and Puerto Rico. Mark A. Winters's co-authors include Mark Holodniy, Robert W. Shafer, Thomas C. Merigan, David Katzenstein, Zhuang Liu, Hongjie Dai, T. C. Merigan, T. C. Merigan, Richard V. Goering and Jonathan Schapiro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Mark A. Winters

109 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Winters United States	37	3.1k	3.0k	1.2k	950	719	113	5.2k
Indira Hewlett United States	33	1.3k 0.4×	1.2k 0.4×	988 0.8×	1.2k 1.3×	250 0.3×	155	3.7k
Helga Rübsamen‐Waigmann Germany	35	1.8k 0.6×	2.1k 0.7×	952 0.8×	1.8k 1.9×	423 0.6×	104	5.1k
Rafaël Delgado Spain	39	2.6k 0.9×	1.6k 0.5×	1.2k 1.0×	1.5k 1.6×	193 0.3×	137	5.6k
Mario Ostrowski Canada	51	1.9k 0.6×	3.2k 1.1×	1.3k 1.1×	1.5k 1.6×	415 0.6×	134	7.3k
Ricardo Sobhie Diaz Brazil	30	2.0k 0.6×	1.9k 0.6×	672 0.6×	346 0.4×	308 0.4×	159	3.1k
Eun‐Young Kim United States	30	1.1k 0.4×	1.9k 0.6×	630 0.5×	1.3k 1.4×	89 0.1×	75	3.7k
Ian M. Jones United Kingdom	51	1.7k 0.6×	2.5k 0.8×	1.7k 1.4×	3.3k 3.5×	567 0.8×	177	8.1k
Scott D. Putney United States	36	1.6k 0.5×	3.6k 1.2×	1.1k 0.9×	2.6k 2.8×	197 0.3×	63	6.8k
He Tian United States	26	2.0k 0.6×	1.7k 0.6×	544 0.5×	649 0.7×	113 0.2×	51	3.8k
William C. Olson United States	47	2.3k 0.8×	4.3k 1.4×	1.0k 0.8×	2.3k 2.4×	449 0.6×	142	7.7k

Countries citing papers authored by Mark A. Winters

Since Specialization

Citations

This map shows the geographic impact of Mark A. Winters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Winters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Winters more than expected).

Fields of papers citing papers by Mark A. Winters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Winters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Winters. The network helps show where Mark A. Winters may publish in the future.

Co-authorship network of co-authors of Mark A. Winters

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Winters. A scholar is included among the top collaborators of Mark A. Winters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Winters. Mark A. Winters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oda, Gina, Mark A. Winters, Monica K Sikka, et al.. (2019). Clusters of nontuberculous mycobacteria linked to water sources at three Veterans Affairs medical centers. Infection Control and Hospital Epidemiology. 41(3). 320–330. 7 indexed citations

Wang, Yan, Jeffrey S. Glenn, Mark A. Winters, et al.. (2018). A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagnostic Microbiology and Infectious Disease. 92(2). 112–117. 7 indexed citations

Rhee, Soo‐Yon, Kris Sankaran, Vici Varghese, et al.. (2016). HIV-1 Protease, Reverse Transcriptase, and Integrase Variation. Journal of Virology. 90(13). 6058–6070. 68 indexed citations

Koh, Christopher, Laëtitia Canini, Harel Dahari, et al.. (2015). Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. The Lancet Infectious Diseases. 15(10). 1167–1174. 187 indexed citations

Kamali, Amanda, Patricia Schirmer, Cynthia Lucero‐Obusan, et al.. (2015). Are current screening protocols for chronic hepatitis B virus infection adequate?. Diagnostic Microbiology and Infectious Disease. 85(2). 159–167. 13 indexed citations

Gish, Robert G., Steve Kane, Margaret D. Clark, et al.. (2013). Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California. Journal of Gastroenterology and Hepatology. 28(9). 1521–1525. 83 indexed citations

Kassaye, Seble, Esther Lee, Rami Kantor, et al.. (2007). Drug Resistance in Plasma and Breast Milk after Single-Dose Nevirapine in Subtype C HIV Type 1: Population and Clonal Sequence Analysis. AIDS Research and Human Retroviruses. 23(8). 1055–1061. 27 indexed citations

Winters, Mark A., et al.. (2005). Ageing in place: intergenerational and intrafamilial housing transfers and shifts in later life. 93 indexed citations

Shulman, Nancy S., Ronald J. Bosch, Mark A. Winters, et al.. (2005). Nonnucleoside Reverse Transcriptase Inhibitor Phenotypic Hypersusceptibility Can Be Demonstrated in Different Assays. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(1). 78–81. 5 indexed citations

10.

Rasmussen, Lucy, Aimee Geissler, & Mark A. Winters. (2003). Inter‐ and Intragenic Variations Complicate the Molecular Epidemiology of Human Cytomegalovirus. The Journal of Infectious Diseases. 187(5). 809–819. 77 indexed citations

11.

Vickrey, John F., et al.. (2003). HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization. Protein Expression and Purification. 28(1). 165–172. 21 indexed citations

12.

Winters, Mark A., Ronald J. Bosch, Mary Albrecht, & David Katzenstein. (2003). Clinical Impact of the M184V Mutation on Switching to Didanosine or Maintaining Lamivudine Treatment in Nucleoside Reverse‐Transcriptase Inhibitor–Experienced Patients. The Journal of Infectious Diseases. 188(4). 537–540. 24 indexed citations

13.

Shulman, Nancy S., Michael D. Hughes, Mark A. Winters, et al.. (2002). Subtle Decreases in Stavudine Phenotypic Susceptibility Predict Poor Virologic Response to Stavudine Monotherapy in Zidovudine-Experienced Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(2). 121–127. 23 indexed citations

14.

Degeling, Pieter, et al.. (2001). Thabo Mbeki and the AIDS 'jury'. Australian Health Review. 24(3). 74–79. 1 indexed citations

15.

Baxter, John D., Douglas L. Mayers, Deborah Wentworth, et al.. (2000). A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. AIDS. 14(9). F83–F93. 379 indexed citations

16.

Schapiro, Jonathan, Mark A. Winters, Jody Lawrence, & Thomas C. Merigan. (1999). Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations. AIDS. 13(3). 359–365. 41 indexed citations

17.

Winters, Mark A., Yvette A. Girard, Hasnah Hamdan, et al.. (1998). A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.. Journal of Clinical Investigation. 102(10). 1769–1775. 195 indexed citations

18.

Rey, David, et al.. (1998). HIV-1 Reverse Transcriptase Codon 215 Mutation in Plasma RNA: Immunologic and Virologic Responses to Zidovudine. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(3). 203–208. 32 indexed citations

19.

Winters, Mark A. & Thomas C. Merigan. (1993). Continuous Presence of CD4-PE40 Is Required for Antiviral Activity Against Single-Passage HIV Isolates and Infected Peripheral Blood Mononuclear Cells. AIDS Research and Human Retroviruses. 9(11). 1091–1096. 8 indexed citations

20.

Hamed, Kamal, Mark A. Winters, Mark Holodniy, David Katzenstein, & T. C. Merigan. (1993). Detection of Human Immunodeficiency Virus Type 1 in Semen: Effects of Disease Stage and Nucleoside Therapy. The Journal of Infectious Diseases. 167(4). 798–802. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact